Advances in pharmacology

1.4k papers and 44.4k indexed citations i.

About

The 1.4k papers published in Advances in pharmacology in the last decades have received a total of 44.4k indexed citations. Papers published in Advances in pharmacology usually cover Molecular Biology (653 papers), Cellular and Molecular Neuroscience (409 papers) and Physiology (163 papers) specifically the topics of Neuroscience and Neuropharmacology Research (216 papers), Receptor Mechanisms and Signaling (193 papers) and Neurotransmitter Receptor Influence on Behavior (153 papers). The most active scholars publishing in Advances in pharmacology are Ferid Murad, Andrew W. Young, David S. Goldstein, Lee E. Eiden and Andrew Young.

In The Last Decade

Fields of papers published in Advances in pharmacology

Since Specialization
EngineeringComputer SciencePhysics and AstronomyMathematicsEarth and Planetary SciencesEnergyEnvironmental ScienceMaterials ScienceChemical EngineeringChemistryAgricultural and Biological SciencesVeterinaryDecision SciencesArts and HumanitiesBusiness, Management and AccountingSocial SciencesPsychologyEconomics, Econometrics and FinanceHealth ProfessionsDentistryMedicineBiochemistry, Genetics and Molecular BiologyNeuroscienceNursingImmunology and MicrobiologyPharmacology, Toxicology and Pharmaceutics

This network shows the specialization of papers published in Advances in pharmacology. Nodes represent fields, and links connect fields that are likely to share authors.

Countries where authors publish in Advances in pharmacology

Since Specialization
Total citations of papers

This map shows the geographic distribution of research published in Advances in pharmacology. It shows the number of citations received by papers published by authors working in each country. You can also color the map by specialization and compare the number of papers published in Advances in pharmacology with the expected number of papers based on a country's size and research output (numbers larger than one mean the country's share of papers is larger than expected).

Rankless by CCL
2025